Skip to main content
. Author manuscript; available in PMC: 2023 Jun 1.
Published in final edited form as: Lancet Respir Med. 2022 Jan 18;10(6):593–602. doi: 10.1016/S2213-2600(21)00503-8

Figure 2: 1-year progression-free survival in the combined cohort for the top biomarkers associated with progressive fibrosing interstitial lung disease after stratification by plasma biomarker concentration quartile.

Figure 2:

Logrank p<0·05 for all presented biomarkers.